| LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects (NCT04865653) | University Hospital, Basel, Switzerland | 2022-03-17 |
| A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides (NCT05296304) | Memorial Sloan Kettering Cancer Center | 2022-03-16 |
| POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer (NCT04826016) | MedSIR | 2022-03-16 |
| Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours (NCT05199753) | LaNova Australia Pty Limited | 2022-03-16 |
| A Study of SKB315 in Patients With Advanced Solid Tumors (NCT05367635) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2022-03-16 |
| An Investigation of Topical Ophthalmic Low-Dose Atropine on Pupil Size and Accommodation (NCT07674966) | University of California, Berkeley | 2022-03-16 |
| Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age (NCT04520659) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-16 |
| Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma (NCT05035862) | Emory University | 2022-03-16 |
| A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer (NCT05241613) | Accutar Biotechnology Inc | 2022-03-16 |
| Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers (NCT05159427) | University of Michigan | 2022-03-15 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 (NCT05200273) | Akeso | 2022-03-15 |
| Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NCT05338931) | AbClon | 2022-03-15 |
| Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) (NCT05203419) | Novartis Pharmaceuticals | 2022-03-15 |
| TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors (NCT04976218) | Chinese PLA General Hospital | 2022-03-15 |
| A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies (NCT05279859) | Erasca, Inc. | 2022-03-15 |
| RBN-2397 in Combination With Pembrolizumab in Patients With SCCL (NCT05127590) | Ribon Therapeutics, Inc. | 2022-03-15 |
| A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies (NCT05253105) | Shanghai Junshi Bioscience Co., Ltd. | 2022-03-15 |
| The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency (NCT06883656) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2022-03-15 |
| A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg (NCT05245084) | Chong Kun Dang Pharmaceutical | 2022-03-15 |
| Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis (NCT05180500) | Sharon Hillier | 2022-03-15 |
| A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC). (NCT05240131) | Galecto Biotech AB | 2022-03-15 |
| Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma (NCT03361852) | Dana-Farber Cancer Institute | 2022-03-14 |
| Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms (NCT05127174) | H. Lee Moffitt Cancer Center and Research Institute | 2022-03-14 |
| A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors (NCT05262400) | Pfizer | 2022-03-14 |
| Targeting CD19/CD20/CD22 Triple-targeted Cell in Patients With Relapsed/Refractory B-cell Lymphoma (NCT05318963) | Institute of Hematology & Blood Diseases Hospital, China | 2022-03-14 |
| Open-label Extension Study of ADP101 (NCT05243719) | Alladapt Immunotherapeutics, Inc. | 2022-03-14 |
| Drug-drug Interaction Study Between Fluconazole and Famitinib in Healthy Subjects (NCT05147727) | Jiangsu HengRui Medicine Co., Ltd. | 2022-03-14 |
| A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Tenofovir Alafenol Fumarate Tablets (TAF) (NCT07002268) | Henan Genuine Biotech Co., Ltd. | 2022-03-14 |
| CNP-201 in Subjects With Peanut Allergy (NCT05250856) | COUR Pharmaceutical Development Company, Inc. | 2022-03-14 |
| A Triple-targeted Cell Preparation Targeting CD19/CD20/CD22 in Patients With Relapsed/Refractory B-cell Acute Lymphocytic Leukemia (NCT05292898) | Institute of Hematology & Blood Diseases Hospital, China | 2022-03-14 |
| Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects (NCT05285137) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2022-03-14 |
| Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) (NCT05289167) | Northwell Health | 2022-03-13 |
| Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product (NCT05332106) | Laboratorios Andromaco S.A. | 2022-03-12 |
| A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors (NCT05235542) | Akeso | 2022-03-12 |
| Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia (NCT05285540) | Design Therapeutics, Inc. | 2022-03-11 |
| Fruquintinib Hepatic Impairment Study (NCT05216367) | Hutchmed | 2022-03-11 |
| GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC (NCT04864054) | Eureka Therapeutics Inc. | 2022-03-11 |
| Fruquintinib Renal Impairment Study (NCT05216354) | Hutchmed | 2022-03-11 |
| A Study of Soticlestat Tablets in Healthy Adults (NCT05284760) | Takeda | 2022-03-11 |
| Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50 (NCT06069687) | The Hospital for Sick Children | 2022-03-11 |
| TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer (NCT05284994) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-03-11 |
| A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers (NCT06481215) | AO GENERIUM | 2022-03-11 |
| Multiple Ascending Dose Study of NH102 in Healthy Subjects (NCT07324408) | Jiangsu Nhwa Pharmaceutical Co., Ltd. | 2022-03-10 |
| Dexamethasone Intravenous Versus Intrathecal in Spinal Anesthesia (NCT05470530) | Ain Shams University | 2022-03-10 |
| A Trial of SHR6508 in Secondary Hyperparathyroidism (NCT05221008) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2022-03-10 |
| IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients (NCT05830539) | InxMed (Shanghai) Co., Ltd. | 2022-03-10 |
| An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of Subjects With Batten Ceroid Lipofuscinosis, Neuronal 3 (CLN3) Disease (NCT05174039) | Beyond Batten Disease Foundation | 2022-03-10 |
| A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants. (NCT05339334) | Pfizer | 2022-03-10 |
| A Study of RNA Tumor Vaccine in Patients With Advanced Solid Tumors (NCT05202561) | The First Affiliated Hospital of Bengbu Medical University | 2022-03-10 |
| Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC (NCT05198856) | Qilu Hospital of Shandong University | 2022-03-10 |
| A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma (NCT05201248) | Genmab | 2022-03-10 |
| Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants. (NCT05282030) | Sanofi | 2022-03-10 |
| Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration (NCT05315700) | ORIC Pharmaceuticals | 2022-03-10 |
| Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants (NCT05263921) | Pfizer | 2022-03-10 |
| Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease (NCT04836429) | Roswell Park Cancer Institute | 2022-03-10 |
| A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea (NCT05180890) | Takeda | 2022-03-10 |
| Test-retest Study With [18F]PI-2620 in PSP-RS and NDC (NCT05187546) | Life Molecular Imaging GmbH | 2022-03-10 |
| A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study (NCT05394714) | Medigen Biotechnology Corporation | 2022-03-10 |
| High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients (NCT05280158) | University of California, Los Angeles | 2022-03-10 |
| Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) (NCT05085977) | Protara Therapeutics | 2022-03-10 |
| A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors (NCT05238883) | HiFiBiO Therapeutics | 2022-03-10 |
| Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD) (NCT05292911) | Altimmune, Inc. | 2022-03-09 |
| A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors (NCT05258266) | Nanjing Zenshine Pharmaceuticals | 2022-03-09 |
| Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism (NCT06293950) | University of Jordan | 2022-03-09 |
| Use of Ozone Gel as an Antimicrobial in Treatment of Periodontitis (NCT05905445) | Ghufran Falih Hassan | 2022-03-09 |
| ASP8374 + Cemiplimab in Recurrent Glioma (NCT04826393) | Dana-Farber Cancer Institute | 2022-03-09 |
| A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma (NCT06561425) | Lakefront Biotherapeutics NV | 2022-03-09 |
| A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia (NCT05326516) | Syndax Pharmaceuticals | 2022-03-09 |
| Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases (NCT04711824) | Colette Shen | 2022-03-09 |
| Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS (NCT05323708) | Biocon Biologics UK Ltd | 2022-03-09 |
| Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir (NCT05236530) | Novartis Pharmaceuticals | 2022-03-09 |
| Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3 (NCT05210504) | Vanderbilt University Medical Center | 2022-03-09 |
| Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray (NCT05248373) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2022-03-08 |
| Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies. (NCT05024305) | Shandong TheraWisdom Biopharma Co., Ltd. | 2022-03-08 |
| An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705 (NCT05295433) | ModernaTX, Inc. | 2022-03-08 |
| Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors (NCT04643418) | MegaPro Biomedical Co. Ltd. | 2022-03-08 |
| Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects (NCT05328726) | Gan and Lee Pharmaceuticals, USA | 2022-03-08 |
| Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE (NCT06015230) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2022-03-08 |
| T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers (NCT05035407) | National Cancer Institute (NCI) | 2022-03-08 |
| Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus (NCT05314738) | Glaukos Corporation | 2022-03-08 |
| Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer (NCT05162118) | Zhejiang University | 2022-03-08 |
| A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers (NCT05248841) | Lannett Company, Inc. | 2022-03-08 |
| A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis (NCT05095246) | Krystal Biotech, Inc. | 2022-03-08 |
| Safety and Tolerability Study of MSC Exosome Ointment (NCT05523011) | Paracrine Therapeutics Dermatology Pte. Ltd. | 2022-03-08 |
| Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects (NCT05252546) | Jiangsu HengRui Medicine Co., Ltd. | 2022-03-08 |
| A Study to Find a Suitable Dose of ASP8731 and Check for Medical Problems at Each Dose in Healthy Adults (NCT05167526) | Astellas Pharma Global Development, Inc. | 2022-03-07 |
| A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects (NCT05325346) | Veralox Therapeutics | 2022-03-07 |
| Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer (NCT05166616) | City of Hope Medical Center | 2022-03-07 |
| A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B) (NCT05277571) | UCB Biopharma SRL | 2022-03-07 |
| SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects (NCT05215808) | Ribon Therapeutics, Inc. | 2022-03-07 |
| AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma (NCT04881032) | Centre Jean Perrin | 2022-03-07 |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT05091424) | Hoffmann-La Roche | 2022-03-07 |
| The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A (NCT05049733) | Johns Hopkins University | 2022-03-07 |
| Colchicine Effect on Perivascular Inflammation Index on Coronary CTA (NCT05347316) | University of Sao Paulo General Hospital | 2022-03-07 |
| Phase I Study of GST-HG151 Tablets in Healthy Volunteers (NCT05345964) | Fujian Cosunter Pharmaceutical Co. Ltd | 2022-03-07 |
| A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric (NCT05315830) | The First Affiliated Hospital of Bengbu Medical University | 2022-03-07 |
| Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine (NCT05276206) | Egymedicalpedia | 2022-03-07 |
| A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes (NCT05298254) | GlaxoSmithKline | 2022-03-07 |
| Image Guided Penile Cancer Surgery (NCT05376202) | University Medical Center Groningen | 2022-03-07 |
| Tarlox and Sotorasib in Patients With KRAS G12C Mutations (NCT05313009) | Medical University of South Carolina | 2022-03-07 |